Mutation Spectrum of the p53 Gene in Bone and Soft Tissue Sarcomas

Cancer Research

Volumn 52, Issue 22, 1992, Pages 6194-6199

  Weichselbaum, Ralph R ^g   Yandell, David W ^a,f   Little, John B ^f   Hen era, Guillermo E ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b Department of Orthopaedic Surgery ^*  (United States)

^c Radiation Biology Center ^*  (United States)

^d KYOTO UNIVERSITY   (Japan)

^e UNIVERSITY OF ALBERTA   (Canada)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CANCER GENETICS; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; SOUTHERN BLOTTING;

ALLELES; BASE SEQUENCE; BLOTTING, SOUTHERN; BONE NEOPLASMS; EXONS; GENE DELETION; GENE REARRANGEMENT; GENES, P53; HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; OSTEOSARCOMA; PHENOTYPE; SARCOMA; SOFT TISSUE NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026464556     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Finlay, C., Hinds, P., and Levine, A. The p53 proto-oncogene can act as a suppressor of transformation. Cell, 57: 1083-1093, 1989.
2. Baker, S., Markowitz, S., Fearon, E., Willson, J., and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249:912-915, 1990.
3. Fields, S., and Jang, S. Presence of a potent transcription activating sequence in the p53 protein. Science (Washington DC), 249: 1046-1049, 1990.
4. Raycroft, L., Wu, H., and Lozano, G. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science (Washington DC), 249: 1049-1051, 1990.
5. Braithwaite, A., Sturzbecher, H-W., Addison, C., Palmer, C., Rudge, K., and Jenkins, J. Mouse p53 inhibits SV 40 origin-dependent DNA replication. Nature (Lond.), 329:458-460, 1987.
6. Gannon, J., and Lane, D. p53 and DNA polymerase a compete for binding to SV 40 antigen. Nature (Lond.), 329:456-458, 1987.
7. Kern, S., Kinzler, K., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., and Vogelstein, B. Identification of p53 as a sequence-specific DNA-binding protein. Science (Washington DC), 252: 1708-1711, 1991.
8. Levine, A., Momand, J., and Finlay, C. The p53 tumor suppressor gene. Nature (Lond.), 351:453-456, 1991.
9. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. p53 mutations in human cancer. Science (Washington DC), 253:49-53, 1991.
10. Baker, S., Presinger, A., Jessup, J., Paraskeva, C., Markowitz, S., Willson, J., Hamilton, S., and Vogelstein, B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50: 7717-7722, 1990.
11. Gaidano, G., Ballerini, P., Gong, J., Inghirami, G., Neri, A., Newcomb, E., Magrath, I., Knowles, D., and Dalla-Favera, R. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA, 88: 5413-5417, 1991.
12. Chiba, I., Takahashi, T., Nau, M., D'Amico, D., Curiel, D., Mitsudomi, T., Buchhagen, D., Carbone, D., Piantadosi, S., Koga, H., Reissman, P., Sla-mon, D., Holmes, E., and Minna, J. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene, 5: 1603-1610, 1990.
13. Hsu, I., Metcalf, R., Sun, T., Welsh, J., Wang, N., and Harris, C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (Lond.), 350:427-428, 1991.
14. Bressac, B., Kew, M., Wands, J., and Ozturk, M. Selective G to T mutations of p53 in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350:429-431, 1991.
15. Masuda, H., Miller, C., Koeffler, H., Battifora, H., and Cline, M. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. Natl. Acad. Sci. USA, 84: 7716-7719, 1987.
16. Maniatis, T., Fritsch, J., and Sambrook, J. (eds.). Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1982.
17. Harlow, E., Williamson, N., Ralston, R., Helfman, D., and Adams, T. Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol. Cell. Biol., 5: 1601-1610, 1985.
18. Lamb, P., and Crawford, L. Characterization of the human p53 gene. Mol. Cell. Biol., 6: 1379-1385, 1986.
19. Toguchida, J., Ishizaki, K., Nakamura, Y., Sasaki, M., Ikenaga, M., Kato, M., Sugimoto, M., Kotoura, Y., and Yamamuro, T. Assignment of common allele loss in osteosarcoma to the subregion 17p13. Cancer Res., 49: 6247-6251, 1989.
20. Nakamura, Y., Lathrop, M., O'Connell, P., Leppert, M., Barker, D., Wright, E., Skolonick, M., Kondoleon, S., Litt, S., Lalouel, J., and White, R. A mapped set of DNA markers for human chromosome 17. Genomics, 2: 302-309, 1988.
21. Yandell, D., and Dryja, T. Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing. Am. J. Hum. Genet., 45: 547-555, 1989.
22. Orita, M., Suzuki, Y., Sekiya, T., and Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5: 874-879, 1989.
23. Soussi, T., de Fromentel, C., and May, P. Structural aspects of the p53 protein in relation to gene evolution. Oncogene, 5:945-952, 1990.
24. Toguchida, J., Ishizaki, K., Sasaki, M., Ikenaga, M., Sugimoto, M., Kotoura, Y., and Yamamuro, T. Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res., 48: 3939-3943, 1988.
25. Mulligan, L., Matlashewski, G., Scrable, H., and Cavenee, W. Mechanisms of p53 loss in human sarcomas. Proc. Natl. Acad. Sci. USA, 87:5863-5867, 1990.
26. Stratton, M., Moss, S., Warren, W., Patterson, H., Clark, J., Fisher, C., Fletcher, C., Ball, A., Thomas, M., Gusterson, B., and Cooper, C. Mutation of thep53 gene in human soft tissue sarcomas: association with abnormalities of the RBI gene. Oncogene, 5: 1297-1301, 1990.
27. Miller, C., Aslo, A., Tsay, C., Slamon, D., Ishizaki, K., Toguchida, J., Yamamuro, T., Lampkin, B., and Koeffler, H. Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res., 50:7950-7954, 1990.
28. Ahuja, H., Bar-Eli, M., Advani, S., Benchimol, S., and Cline, M. Alterations in the p53 gene and the clonal evolution of the balst crisis of chronic myelocytic leukemia. Proc. Natl. Acad. Sci. USA, 86: 6783-6787, 1989.
29. Kelman, Z., Prokocimer, M., Peller, S., Kahn, Y., Rechavi, G., Manor, Y., Cohen, A., and Rotter, V. Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia. Blood, 74:2318-2324, 1989.
30. Soussi, T., de Fromental, C., Sturzbecher, H., Ullrich, S., Jenkins, J., and May, P. Evolutionary conservation of the biochemical properties of p53: specific interactions of Xenopus laevis p53 with simian virus large T antigen and mammalian heat shock proteins 70. J. Virol., 63: 3894-3901, 1989.
31. Milner, J., Medcalf, E., and Cook, A. Tumor suppressor p53: analysis of wild-type and mutant p53 complexes. Mol. Cell. Biol., 11: 12-19, 1991.
32. Toguchida, J., Yamaguchi, T., Dayton, S., Beauchamp, R., Herrera, G., Ishizaki, K., Yamamuro,T., Meyers, P., Little, J., Sasaki, M., Weichselbaum, R., and Yandell, D. Prevalence and spectrum of germ-line p53 gene mutations among patients with sarcoma. N. Engl. J. Med., 326:1301-1308.1992.
33. Sakai, T., Ohtani, N., McGee, T., Robins, P., and Dryja, T. Oncogenic germ-line mutations in Spl and AFT sites in the human retinoblastoma gene. Nature (Lond.), 353: 83-86, 1991.
34. Sato, T., Tanigami, A., Yamakawa, K., Akiyama, F., Kasumi, F., Sakamoto, G., and Nakamura, Y. Allelotype of breast cancer: accumulative allele losses promote tumor progression in primary breast cancer. Cancer Res., 50:7184-7189, 1990.
35. Fujimori, M., Tokino, T., Hino, O., Kitagawa, T., Imamura, T., Okamoto, E., Mitsunobu, M., Ishikawa, T., Nakagama, H., Harada, H., Yagura, M., Matsubara, K., and Nakamura, Y. Allelotype study of primary hepatocellular carcinoma. Cancer Res., 51: 89-93, 1991.
36. Barlow, D., Stoger, R., Herrmann, B., Saito, K., and Schweifer, N. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature (Lond.), 349: 84-87, 1991.
37. DeChiara, T., Robertson, E., and Efstratiadis, A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell, 64: 849-859, 1991.